CTLA4 and melanoma: Another study illustrated enhanced rejection of B16-OVA melanoma cells using ovalbumin-producing Salmonella and αPD-L1 compared to Salmonella alone or combination of PD-L1 and CTLA-4 inhibitors through enhancing the expansion of CD8+ T cells (104).